BNR

NASDAQStock

Burning Rock Biotech Limited

$22.85-0.61 (-2.60%)

52-Week Range

$2.32
$41.06

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

Volume

3.7K

Avg Volume

24.4K

Performance

1M

-26.29%

3M

+45.08%

6M

+162.34%

YTD

+16.11%

1Y

+323.93%

3Y

-18.39%

5Y

-91.04%

Price Chart

ETF Exposure

BNR is held by 14 ETFs

ETFFund NameWeight
DINTDavis Select International ETF1.48%
CHNALoncar China BioPharma ETF1.29%
RBINNationwide Risk-Based International Equity ETF0.34%
PQINPGIM Quant Solutions Strategic Alpha International Equity ETF0.25%
HFXEIQ 50 Percent Hedged FTSE Europe ETF0.20%
PXUSPrincipal International Adaptive Multi-Factor ETF0.11%
EHLSEven Herd Long Short ETF0.05%
FNDFSchwab Fundamental International Large Company Index ETF0.04%
HFXINYLI FTSE International Equity Currency Neutral ETF0.04%
NTSIWisdomTree International Efficient Core Fund0.04%
TACNT. Rowe Price Active Core International Equity ETF0.03%
SCHFSchwab International Equity ETF0.02%
TLTDFlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund0.01%
MFDXPIMCO RAFI Dynamic Multi-Factor International Equity ETF0.01%

About BNR ETF Exposure

Burning Rock Biotech Limited (BNR) is held by 14 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $22.85. Investors can gain exposure to BNR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BNR, sorted by portfolio weight.